These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8387400)

  • 1. Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766.
    Hamers FP; Pette C; Bravenboer B; Vecht CJ; Neijt JP; Gispen WH
    Cancer Chemother Pharmacol; 1993; 32(2):162-6. PubMed ID: 8387400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats.
    Gerritsen van der Hoop R; de Koning P; Boven E; Neijt JP; Jennekens FG; Gispen WH
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):637-42. PubMed ID: 2838292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats.
    Hamers FP; Brakkee JH; Cavalletti E; Tedeschi M; Marmonti L; Pezzoni G; Neijt JP; Gispen WH
    Cancer Res; 1993 Feb; 53(3):544-9. PubMed ID: 8425186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence.
    Gerritsen van der Hoop R; Hamers FP; Neijt JP; Veldman H; Gispen WH; Jennekens FG
    J Neurol Sci; 1994 Nov; 126(2):109-15. PubMed ID: 7853014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons.
    Müller LJ; Gerritsen van der Hoop R; Moorer-van Delft CM; Gispen WH; Roubos EW
    Cancer Res; 1990 Apr; 50(8):2437-42. PubMed ID: 2156619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Org.2766 protects from cisplatin-induced neurotoxicity in rats.
    de Koning P; Neijt JP; Jennekens FG; Gispen WH
    Exp Neurol; 1987 Sep; 97(3):746-50. PubMed ID: 3040462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats.
    Hamers FP; van der Hoop RG; Steerenburg PA; Neijt JP; Gispen WH
    Toxicol Appl Pharmacol; 1991 Dec; 111(3):514-22. PubMed ID: 1660632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.
    Bravenboer B; Kappelle AC; van Buren T; Erkelens DW; Gispen WH
    Acta Diabetol; 1993; 30(1):21-4. PubMed ID: 8392402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats.
    Hamers FP; Pette C; Neijt JP; Gispen WH
    Eur J Pharmacol; 1993 Mar; 233(1):177-8. PubMed ID: 8097161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats.
    Van der Zee CE; Van der Hoop RG; Gispen WH
    Diabetes; 1989 Feb; 38(2):225-30. PubMed ID: 2536628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats.
    Bárdos G; Móricz K; Jaszlits L; Rabloczky G; Tory K; Rácz I; Bernáth S; Sümegi B; Farkas B; Literáti-Nagy B; Literáti-Nagy P
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):9-16. PubMed ID: 12831778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ACTH-(4-9) analogue, Org 2766, improves recovery from acrylamide neuropathy in rats.
    Sporel-Ozakat RE; Edwards PM; Van der Hoop RG; Gispen WH
    Eur J Pharmacol; 1990 Sep; 186(2-3):181-7. PubMed ID: 1963145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro.
    Hol EM; Mandys V; Sodaar P; Gispen WH; Bär PR
    J Neurosci Res; 1994 Oct; 39(2):178-85. PubMed ID: 7837287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat.
    De Koning P; Gispen WH
    Peptides; 1987; 8(3):415-22. PubMed ID: 2821519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat.
    McKeage MJ; Boxall FE; Jones M; Harrap KR
    Cancer Res; 1994 Feb; 54(3):629-31. PubMed ID: 8306321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular distribution of cis-diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: effect of the neuroprotecting peptide ORG.2766.
    Terheggen PM; van der Hoop RG; Floot BG; Gispen WH
    Toxicol Appl Pharmacol; 1989 Jun; 99(2):334-43. PubMed ID: 2544043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of cisplatin-induced neuropathy: recent developments.
    Hamers F; Neijt J; Gispen W
    Pathol Biol (Paris); 1992 Nov; 39(9):829-30. PubMed ID: 1311436
    [No Abstract]   [Full Text] [Related]  

  • 18. ACTH/MSH like peptides in the treatment of cisplatin neuropathy.
    Gispen WH; Hamers FP; Vecht CJ; Jennekens FG; Neyt JP
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):179-83. PubMed ID: 1326318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor prevents experimental cisplatin neuropathy.
    Apfel SC; Arezzo JC; Lipson L; Kessler JA
    Ann Neurol; 1992 Jan; 31(1):76-80. PubMed ID: 1543351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
    Bravenboer B; Erkelens DW; Gispen WH
    Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.